Literature DB >> 16647424

Vitamin E status in children with cystic fibrosis and pancreatic insufficiency.

Shirley H Huang1, Joan I Schall, Babette S Zemel, Virginia A Stallings.   

Abstract

Vitamin E status was compared in 69 children (7.0-10.0 years) with cystic fibrosis and pancreatic with the National Health and Nutrition Examination Survey III sample (6.0-11.9 years). With median vitamin E intakes of 6 mg/day (dietary) and 224 mg/day (supplemental), children with cystic fibrosis had higher serum alpha-tocopherol:cholesterol ratios, higher alpha-tocopherol, and lower cholesterol levels than in the National Health and Nutrition Examination Survey.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16647424     DOI: 10.1016/j.jpeds.2005.11.016

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  8 in total

1.  Selection bias and vitamin E status in cystic fibrosis.

Authors:  Ronald J Sokol
Journal:  J Pediatr       Date:  2007-05       Impact factor: 4.406

2.  Why bother to take vitamins?

Authors:  Alison Morton
Journal:  J R Soc Med       Date:  2011-07       Impact factor: 5.344

3.  Lipid mapping of colonic mucosa by cluster TOF-SIMS imaging and multivariate analysis in cftr knockout mice.

Authors:  Marc Brulet; Alexandre Seyer; Aleksander Edelman; Alain Brunelle; Janine Fritsch; Mario Ollero; Olivier Laprévote
Journal:  J Lipid Res       Date:  2010-07-08       Impact factor: 5.922

Review 4.  Cystic fibrosis-related oxidative stress and intestinal lipid disorders.

Authors:  Marie-Laure Kleme; Emile Levy
Journal:  Antioxid Redox Signal       Date:  2015-01-22       Impact factor: 8.401

5.  Salvianolic acid B prevents epithelial-to-mesenchymal transition through the TGF-beta1 signal transduction pathway in vivo and in vitro.

Authors:  Qing-Lan Wang; Yan-Yan Tao; Ji-Li Yuan; Li Shen; Cheng-Hai Liu
Journal:  BMC Cell Biol       Date:  2010-05-05       Impact factor: 4.241

6.  Relationship Between Fat-Soluble Vitamin Supplementation and Blood Concentrations in Adolescent and Adult Patients With Cystic Fibrosis.

Authors:  Oranan Siwamogsatham; Wei Dong; Jose N Binongo; Ritam Chowdhury; Jessica A Alvarez; Shawna J Feinman; Jessica Enders; Vin Tangpricha
Journal:  Nutr Clin Pract       Date:  2014-04-17       Impact factor: 3.080

7.  Fat-soluble vitamins in cystic fibrosis and pancreatic insufficiency: efficacy of a nutrition intervention.

Authors:  Chiara Bertolaso; Veronique Groleau; Joan I Schall; Asim Maqbool; Maria Mascarenhas; Norma E Latham; Kelly A Dougherty; Virginia A Stallings
Journal:  J Pediatr Gastroenterol Nutr       Date:  2014-04       Impact factor: 2.839

8.  CFTR Modulator Therapy with Lumacaftor/Ivacaftor Alters Plasma Concentrations of Lipid-Soluble Vitamins A and E in Patients with Cystic Fibrosis.

Authors:  Olaf Sommerburg; Susanne Hämmerling; S Philipp Schneider; Jürgen Okun; Claus-Dieter Langhans; Patricia Leutz-Schmidt; Mark O Wielpütz; Werner Siems; Simon Y Gräber; Marcus A Mall; Mirjam Stahl
Journal:  Antioxidants (Basel)       Date:  2021-03-19
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.